inclusion criteria: subjects eligible for inclusion in this study must meet all of the following criteria: 1. written informed consent must be obtained before any assessment is performed 2. hospitalized due to covid-19 infection 3. documented sars-cov2 acute myocardial injury: defined as upper respiratory tract specimen positive for covid-19 and troponin t greater than 99th percentile upper reference range without signs or symptoms of acute myocardial ischemia 4. nt-probnp greater than the age-adjusted upper reference limit 5. receiving current standard therapy 6. c-reactive protein (crp) \> 50 mg/l

inclusion criteria: subjects eligible for inclusion in this study must meet all of the following criteria: 1. written informed consent must be obtained before any assessment is performed 2. hospitalized due to covid-19 infection 3. documented sars-cov2 acute myocardial injury: defined as upper respiratory tract specimen positive for covid-19 and troponin t greater than 99th percentile upper reference range without signs or symptoms of acute myocardial ischemia 4. nt-probnp greater than the age-adjusted upper reference limit 5. receiving current standard therapy 6. c-reactive protein (crp) \> 50 mg/l

inclusion criteria: subjects eligible for inclusion in this study must meet all of the following criteria: written informed consent must be obtained before any assessment is performed hospitalized due to covid-19 infection documented sars-cov2 acute myocardial injury: defined as upper respiratory tract specimen positive for covid-19 and troponin t greater than 99th percentile upper reference range without signs or symptoms of acute myocardial ischemia nt-probnp greater than the age-adjusted upper reference limit receiving current standard therapy c-reactive protein (crp) > 50 mg/l

inclusion criteria: subjects eligible for inclusion in this study must meet all of the following criteria: written informed consent must be obtained before any assessment is performed hospitalized due to covid-19 infection documented sars-cov2 acute myocardial injury: defined as upper respiratory tract specimen positive for covid-19 and troponin t greater than 99th percentile upper reference range without signs or symptoms of acute myocardial ischemia nt-probnp greater than the age-adjusted upper reference limit receiving current standard therapy c-reactive protein (crp) > 50 mg/l

inclusion criteria: subjects eligible for inclusion in this study must meet all of the following criteria: 1. written informed consent must be obtained before any assessment is performed 2. hospitalized due to covid-19 infection 3. documented sars-cov2 acute myocardial injury: defined as upper respiratory tract specimen positive for covid-19 and troponin t greater than 99th percentile upper reference range without signs or symptoms of acute myocardial ischemia 4. nt-probnp greater than the age-adjusted upper reference limit 5. receiving current standard therapy 6. c-reactive protein (crp) > 50 mg/l

inclusion criteria: subjects eligible for inclusion in this study must meet all of the following criteria: 1. written informed consent must be obtained before any assessment is performed 2. hospitalized due to covid-19 infection 3. documented sars-cov2 acute myocardial injury: defined as upper respiratory tract specimen positive for covid-19 and troponin t greater than 99th percentile upper reference range without signs or symptoms of acute myocardial ischemia 4. nt-probnp greater than the age-adjusted upper reference limit 5. receiving current standard therapy 6. c-reactive protein (crp) > 50 mg/l